CLINICAL_TRIALS
trial_result
· 2009-01-27
Clinical Trial Update: Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast Cancer [Phase 1]
Summary
Pfizer conducted a Phase 1 study of SU011248 in combination with paclitaxel for metastatic breast cancer; the trial status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Breast Neoplasms | Phase 1 | Status: COMPLETED